» Articles » PMID: 34988531

Management of Ventricular Arrhythmias in Heart Failure: Current Perspectives

Overview
Journal Heart Rhythm O2
Date 2022 Jan 6
PMID 34988531
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Congestive heart failure (HF) is a progressive affliction defined as the inability of the heart to sufficiently maintain blood flow. Ventricular arrhythmias (VAs) are common in patients with HF, and conversely, advanced HF promotes the risk of VAs. Management of VA in HF requires a systematic, multimodality approach that comprises optimization of medical therapy and use of implantable cardioverter-defibrillator and/or device combined with cardiac resynchronization therapy. Catheter ablation is one of the most important strategies with the potential to abolish or decrease the number of recurrences of VA in this population. It can be a curative strategy in arrhythmia-induced cardiomyopathy and may even save lives in cases of an electrical storm. Additionally, modulation of the autonomic nervous system and stereotactic radiotherapy have been introduced as novel methods to control refractory VAs. In patients with end-stage HF and refractory VAs, an institution of the mechanical circulatory support device and cardiac transplant may be considered. This review aims to provide an overview of current evidence regarding management strategies of VAs in HF with an emphasis on interventional treatment.

Citing Articles

Antiarrhythmic Treatment in Heart Failure.

Konemann H, Guler-Eren S, Ellermann C, Frommeyer G, Eckardt L Curr Heart Fail Rep. 2024; 21(1):22-32.

PMID: 38224446 PMC: 10828006. DOI: 10.1007/s11897-023-00642-w.


The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China.

Lian R, Zhang G, Yan S, Sun L, Gao W, Yang J Front Pharmacol. 2022; 13:930245.

PMID: 36249764 PMC: 9561246. DOI: 10.3389/fphar.2022.930245.


Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond.

Cumberland M, Riebel L, Roy A, OShea C, Holmes A, Denning C Front Physiol. 2022; 13:806366.

PMID: 35197863 PMC: 8859441. DOI: 10.3389/fphys.2022.806366.

References
1.
Proietti R, Essebag V, Beardsall J, Hache P, Pantano A, Wulffhart Z . Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. Europace. 2014; 17(3):461-7. DOI: 10.1093/europace/euu326. View

2.
Kowlgi G, Cha Y . Management of ventricular electrical storm: a contemporary appraisal. Europace. 2020; 22(12):1768-1780. DOI: 10.1093/europace/euaa232. View

3.
. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 353(9169):2001-7. View

4.
Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A . 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical.... J Am Coll Cardiol. 2017; 72(14):1677-1749. DOI: 10.1016/j.jacc.2017.10.053. View

5.
Galand V, Flecher E, Auffret V, Boule S, Vincentelli A, Dambrin C . Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices. JACC Clin Electrophysiol. 2018; 4(9):1166-1175. DOI: 10.1016/j.jacep.2018.05.006. View